Skip to content
  • Publications
  • Training
  • FAQs
  • M&E Dashboard
  • Vacancies
Menu
  • Publications
  • Training
  • FAQs
  • M&E Dashboard
  • Vacancies
Contact
  • COVID-19
    • SARS-COV-2 Rapid Test Reporting
    • TrakCare Lab Webview
    • COVID-19 Frequently Asked Questions
    • COVID-19 Returning to Work FAQs
    • COVID-19 Surveillance Reports
    • COVID-19 Vaccine
    • Variant Tracking in South Africa
    • COVID-19 Technical Resources
    • COVID-19 Guidelines
    • COVID-19 Advice for The Public
    • COVID-19 Prevention
    • COVID-19 Advice for Travellers
    • Long COVID
    • COVID-19 Vaccine Breakthrough Cases Frequently Asked Questions
    • COVID-19 Resources for Children
    • COVID-19 Communication Resources
    • COVID-19 Contact Resources
  • About Us
    • Overview
    • Our Objectives
    • Management
    • Our Partners
    • Data protection and privacy policy
  • Centres
    • Centre for Emerging Zoonotic and Parasitic Diseases
    • Centre for Enteric Diseases
    • Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses
    • Centre for HIV and STIs
    • Centre for Respiratory Diseases and Meningitis
    • Centre for Tuberculosis
    • Centre for Vaccines and Immunology
    • Division of Public Health, Surveillance and Response
    • National Cancer Registry
      • Cancer Statistics
    • Transversal Functions
  • Our Services
    • Surveillance
    • Training
    • Outbreak Response
    • Research
    • Proficiency Testing Schemes
    • Diagnostic Services
  • Notifiable Medical Conditions
    • Overview
    • Notification Process
    • Tutorial Videos
    • Notification Forms
    • NMC COVID-19 Documents
    • Contacts
  • Media
    • Alerts
    • News
    • Videos
    • Podcasts
    • Blogs
Menu
  • COVID-19
    • SARS-COV-2 Rapid Test Reporting
    • TrakCare Lab Webview
    • COVID-19 Frequently Asked Questions
    • COVID-19 Returning to Work FAQs
    • COVID-19 Surveillance Reports
    • COVID-19 Vaccine
    • Variant Tracking in South Africa
    • COVID-19 Technical Resources
    • COVID-19 Guidelines
    • COVID-19 Advice for The Public
    • COVID-19 Prevention
    • COVID-19 Advice for Travellers
    • Long COVID
    • COVID-19 Vaccine Breakthrough Cases Frequently Asked Questions
    • COVID-19 Resources for Children
    • COVID-19 Communication Resources
    • COVID-19 Contact Resources
  • About Us
    • Overview
    • Our Objectives
    • Management
    • Our Partners
    • Data protection and privacy policy
  • Centres
    • Centre for Emerging Zoonotic and Parasitic Diseases
    • Centre for Enteric Diseases
    • Centre for Healthcare-Associated Infections, Antimicrobial Resistance and Mycoses
    • Centre for HIV and STIs
    • Centre for Respiratory Diseases and Meningitis
    • Centre for Tuberculosis
    • Centre for Vaccines and Immunology
    • Division of Public Health, Surveillance and Response
    • National Cancer Registry
      • Cancer Statistics
    • Transversal Functions
  • Our Services
    • Surveillance
    • Training
    • Outbreak Response
    • Research
    • Proficiency Testing Schemes
    • Diagnostic Services
  • Notifiable Medical Conditions
    • Overview
    • Notification Process
    • Tutorial Videos
    • Notification Forms
    • NMC COVID-19 Documents
    • Contacts
  • Media
    • Alerts
    • News
    • Videos
    • Podcasts
    • Blogs
Search
Close
Search
Close
  • OVERVIEW
  • OUR OBJECTIVES
  • MANAGEMENT
  • OUR PARTNERS
  • DATA PROTECTION AND PRIVACY POLICY
Menu
  • OVERVIEW
  • OUR OBJECTIVES
  • MANAGEMENT
  • OUR PARTNERS
  • DATA PROTECTION AND PRIVACY POLICY

Adverse event following immunization (AEFI)

Diseases A-Z Index Adverse event following immunization (AEFI)

Diseases A-Z Index:
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • W
  • V
  • X
  • Y
  • Z

What are Adverse Events Following Immunization?

Any medical event occurring after immunisation can be classified as an adverse event following immunisation (AEFI) whether the event has any causal relationship to getting the immunisation or not. 

Adverse events/responses following immunisation can range from mild to severe and from common to very rare. They may occur as a result of the immunisation, a causal relationship between the event and immunisation, or occur after the immunisation by chance, a coincidental relationship between the event and immunisation.

*Please use the forms below to report an adverse event following immunization with any vaccine, including SARS-CoV-2 vaccines

CASE REPORTING FORM (CRF) FOR ADVERSE EVENTS FOLLOWING IMMUNISATION (AEFI) (2021)
CASE REPORTING FORM (CRF) FOR SUSPECTED ADVERSE EVENTS OF SPECIAL INTEREST (AESI)(2021)
CASE INVESTIGATION FORM (CIF) Adverse Events Following Immunisation (AEFI) AND Adverse Events of Special Interest (AESI) (2021)

Share

Share on facebook
Share on twitter
Facebook Instagram Linkedin Twitter Youtube

Quick Links

  • M&E Dashboard
  • Publications
  • Vacancies
  • Researcher Directory
  • Terms and Conditions

Download NMC

  • Android App
  • Huawei App
  • Web Portal
  • Apple App

Connect with our Researchers

Contact Us

© NICD 2021. All Rights Reserved
Disclaimer: The National Institute for Communicable Diseases does not provide Medical Advice to the public. For Medical Advice, please consult your Healthcare provider.